Latest Development Activity News

Lion Selection Group has committed $1 million to Sunshine Metals, increasing its stake to 9.2% as Sunshine advances promising high-grade gold projects in North Queensland.

Lode Resources has agreed to sell its Webbs Consol Silver Project to Rapid Critical Metals for A$3.75 million in cash, a significant shareholding, and a royalty, positioning both companies for strategic growth in New South Wales.

Tamboran Resources has secured a pioneering approval from the Northern Territory Government to sell appraisal gas from its Beetaloo Basin exploration permits, marking a significant step toward local energy supply and revenue generation.

Buru Energy has successfully raised $2.1 million through a share placement and launched a $3 million Share Purchase Plan to advance its Rafael Gas Project, targeting a Final Investment Decision by late 2026 and first cash flow by early 2028.

Gateway Mining has appointed seasoned geologist Richard Pugh as CEO, aiming to leverage his deep Yandal Project expertise to fast-track exploration and resource expansion.

Cyclone Metals has launched a comprehensive Pre-Feasibility Study for its Iron Bear iron ore project in Canada, aiming to refine development plans and attract global steel market demand.

Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.

Perpetual Resources has launched a prospectus to enable trading of new options issued alongside a recent $1.6 million placement, aiming to unlock liquidity while outlining key risks for investors.

Papyrus Australia Ltd reported a sharp increase in losses for FY2025, driven by impairment of its Egyptian investments, while securing new funding and advancing commercialization of its banana fibre technology.

Axiom Properties Limited reports a 55% reduction in net loss for FY25, completing its Glenlea Estate sales and accelerating its Property Technology strategy with a $30 million debt facility for PaySure.

Alligator Energy has lodged a Prospectus for Placement Options following its June 2025 capital raise, setting the stage for potential shareholder dilution and future funding opportunities.

Alterity Therapeutics reported a reduced net loss of A$12.15 million for FY2025, buoyed by positive Phase 2 clinical trial results for its lead drug ATH434 in Multiple System Atrophy and a successful A$40 million capital raising.